LyGenesis
Pittsburgh
About LyGenesis
LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $37.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2023)
- Website: lygenesis.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Medical
Social Profiles
Canonical: https://fsome.com/organization/lygenesis-89398 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.